Boston Scientific Corporation's (BSX) stock has garnered great interest from the street and hedge funds. Key movements include stock holdings being increased by
Egerton Capital UK LLP, lowered by Artisan Partners Limited Partnership, and decreased by Dana Investment Advisors Inc.
Quantbot Technologies LP purchased 117, 637 Shares while
Intech Investment Management LLC sold Boston Scientific shares. Majorly,
Truist cut the BSX price target but maintained the buy rating despite the earnings pullback.
Fiera Capital Corp and
Fortis Capital Management LLC have taken a position in BSX, as has the
Investment Group Partners LLC. BSX's stock had its share buyback program increased by $4 billion. A significant plummet was reported despite mixed Q4 earnings, pulled down by a cautious 2026 revenue forecast. Starbucks CFO and Takeda CEO have been elected to the board of Boston Scientific. BSX's short interest update and adjustments of price targets by Argus are reported. Lastly, Boston Scientific has announced results for its second and third quarter of 2025.
Boston Scientific Corp BSX News Analytics from Wed, 23 Jul 2025 07:00:00 GMT to Sat, 28 Feb 2026 13:56:59 GMT -
Rating -5
- Innovation 3
- Information 9
- Rumor -2
